Press Releases July 2nd, 2025: MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease in Europe MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease…MaaT PharmaJuly 2, 2025
Press Releases September 4, 2024: MaaT Pharma To Present and Participate in Investor and Medical Conferences in September MaaT Pharma To Present and Participate in Investor and Medical Conferences in September Lyon, France,…MaaT PharmaSeptember 4, 2024
Press Releases June 25, 2024: MaaT Pharma Announces Initiation of Coverage of its Stock by Stifel with a Buy Rating and a Target Price of EUR 16 MaaT Pharma Announces Initiation of Coverage of its Stock by Stifel with a Buy Rating…MaaT PharmaJune 25, 2024
Press Releases June 24, 2024: MaaT Pharma Appoints Gianfranco Pittari, M.D. Ph.D, as Chief Medical Officer MaaT Pharma Appoints Gianfranco Pittari, M.D. Ph.D, as Chief Medical Officer Lyon, France, June 24th…MaaT PharmaJune 24, 2024
Press Releases May 29, 2024: MaaT Pharma Presents the Results of its Annual Ordinary and Extraordinary General Meeting MaaT Pharma Presents the Results of its Annual Ordinary and Extraordinary General Meeting Lyon, France,…MaaT PharmaMay 29, 2024
Press Releases May 15, 2024: MaaT Pharma announces the successful completion of its Global Offering of 19.2 Million Euros THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION…MaaT PharmaMay 15, 2024
Press Releases May 14, 2024: MaaT Pharma Launches a Global Offering of approximately 18 Million Euros THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION…MaaT PharmaMay 14, 2024
Press Releases May 7, 2024: MaaT Pharma Provides a Business Update and Highlights Key Milestones Expected in 2024 MaaT Pharma Provides a Business Update and Highlights Key Milestones Expected in 2024 Positive efficacy…MaaT PharmaMay 7, 2024
Press Releases April 5, 2024: MaaT Pharma Announces Initiation of Coverage of its Stock by Gilbert Dupont/ Groupe Société Générale MaaT Pharma Announces Initiation of Coverage of its Stock by Gilbert Dupont/ Groupe Société Générale…MaaT PharmaApril 5, 2024
Press Releases March 21, 2024: MaaT Pharma Strengthens Executive Team Appointing Jonathan Chriqui as Chief Business Officer MaaT Pharma Strengthens Executive Team Appointing Jonathan Chriqui as Chief Business Officer Lyon, France, March…MaaT PharmaMarch 21, 2024